Results 21 to 30 of about 42,942 (233)
Cancer Management and Research, 2021 Qiang Yi, Yu Ran, Cong Li Department of Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of ChinaCorrespondence: Cong Li No.
Yi Q, Ran Y, Li C
doaj
CA125 Expression in Epithelioid Sarcoma [PDF]
Japanese Journal of Clinical Oncology, 2004 There has been no report on useful immunohistological markers for epithelioid sarcoma (ES) so far. The purpose of this study is to evaluate the positivity and specificity of CA125 as a marker for the correct diagnosis of ES.This study was performed in 11 patients with ES (nine men and two women; distal type: 10 cases; proximal type: one case), 78 ...
Hiroshi, Kato +9 more
openaire +2 more sources
Human epididymis protein 4 (HE4) in benign and malignant diseases [PDF]
, 2012 Background: Human epididymis protein 4 (HE4) is described as a useful new biomarker in ovarian cancer. As HE4 is neither tumor nor organ specific, we intensively investigated the occurrence of this protein in female and male patients with various benign ...
Anastasi +39 more
core +1 more source
CA125 and Ovarian Cancer: A Comprehensive Review [PDF]
Cancers, 2020 Ovarian cancer is the second most lethal gynecological malignancy. The tumour biomarker CA125 has been used as the primary ovarian cancer marker for the past four decades. The focus on diagnosing ovarian cancer in stages I and II using CA125 as a diagnostic biomarker has not improved patients’ survival.
Parsa Charkhchi +5 more
openaire +3 more sources
Improved early detection of ovarian cancer using longitudinal multimarker models [PDF]
, 2019 © The Author(s) 2020. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the ...
Blyuss, Oleg +10 more
core +3 more sources
Exploring the Glycosylation of Serum CA125 [PDF]
International Journal of Molecular Sciences, 2013 Ovarian cancer is the most lethal gynaecologic cancer affecting women. The most widely used biomarker for ovarian cancer, CA125, lacks sensitivity and specificity. Here, we explored differences in glycosylation of CA125 between serum from patients with ovarian cancer and healthy controls.
Radka Saldova +5 more
openaire +2 more sources
Journal of Obstetrics and Gynaecology, 2013 A total of 50 women having uterine enlargement of > 12 weeks' size due to severe adenomyosis with raised CA125, were carefully studied and compared with other cases. The greater the enlargement of the uterus over 240 cm(3) volume or 12 weeks' uterine size due to severe adenomyosis, the greater was the rise of CA125 levels and these were disturbingly ...
S S, Sheth, S S, Ray
openaire +2 more sources
Role of Serum Tumor Markers in Prognosis of Operable Non-small Cell Lung Cancer Patients
Zhongliu Fangzhi Yanjiu, 2018 Objective To evaluate the prognostic value of CEA, CA125, CA199, NSE, CYFRA21-1 and SCC-Ag as serum tumor markers on the diagnosis of operable non-small cell lung cancer(NSCLC) after radical operation.
LI Shaolei +5 more
doaj +1 more source
Carboplatin/taxane-induced gastrointestinal toxicity: a pharmacogenomics study on the SCOTROC1 trial [PDF]
, 2016 Carboplatin/taxane combination is first-line therapy for ovarian cancer. However, patients can encounter treatment delays, impaired quality of life, even death because of chemotherapy-induced gastrointestinal (GI) toxicity.
Brown, R. +7 more
core +1 more source
The Expression of The Autophagy Gene Beclin-1 mRNA and Protein in Ectopic and Eutopic Endometrium of Patients with Endometriosis [PDF]
International Journal of Fertility and Sterility, 2015 Background To investigate the expression of Beclin-1 mRNA and protein in eutopic and ectopic endometrium of women with and without endometriosis, and evaluate the association of Beclin-1 protein expression and serum CA125 levels in the endometriosis ...
Longyu Zhang +4 more
doaj +1 more source